Clinical Trial

A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously in Healthy Participants

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated January 20, 2026 (before its estimated June 23, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to test the safety of mRNA-0184 in healthy participants.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-10-22; most recent amendment 2026-01-15.
Status change: Recruiting → Active, Not Recruiting 2026-01-15
Status change: Not Yet Recruiting → Recruiting 2024-11-26
Trial Details
NCT Number NCT06655870
Lead Sponsor ModernaTX, Inc.
Conditions Healthy Participants
Enrollment 52 participants
Start Date 2024-10-31
Primary Completion 2026-06-23 (estimated)
Study Completion 2026-06-23 (estimated)
Updated on ClinicalTrials.gov 2026-01-20